tiprankstipranks
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
Canadian Market

HLS Therapeutics Inc (HLS) Stock Forecast & Price Target

Compare
43 Followers
See the Price Targets and Ratings of:

HLS Financial Forecast

HLS Earnings Forecast

Next quarter’s earnings estimate for HLS is -C$0.13 with a range of -C$0.16 to -C$0.11. The previous quarter’s EPS was -C$0.21. HLS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.17% of the time in the same period. In the last calendar year HLS has Preformed in-line its overall industry.
Next quarter’s earnings estimate for HLS is -C$0.13 with a range of -C$0.16 to -C$0.11. The previous quarter’s EPS was -C$0.21. HLS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.17% of the time in the same period. In the last calendar year HLS has Preformed in-line its overall industry.

HLS Sales Forecast

Next quarter’s sales forecast for HLS is C$22.36M with a range of C$22.07M to C$22.79M. The previous quarter’s sales results were C$19.21M. HLS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.74% of the time in the same period. In the last calendar year HLS has Preformed in-line its overall industry.
Next quarter’s sales forecast for HLS is C$22.36M with a range of C$22.07M to C$22.79M. The previous quarter’s sales results were C$19.21M. HLS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.74% of the time in the same period. In the last calendar year HLS has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bloom Burton
C$9.5
Buy
128.92%
Upside
Reiterated
11/08/24
Optimistic Buy Rating for HLS Therapeutics Despite Revenue Challenges
Stifel Nicolaus
C$3.75C$3.25
Hold
-21.69%
Downside
Reiterated
08/13/24
HLS Therapeutics (HLS:CN) (HLTRF) PT Lowered to Cdn$3.25 at Stifel CanadaStifel Canada analyst Justin Keywood lowered the price target on HLS Therapeutics (HLS:CN) (OTC: HLTRF) to Cdn$3.25 (from Cdn$3.75) while maintaining a Hold rating.
Canaccord Genuity
C$4.75C$4
Hold
-3.61%
Downside
Reiterated
05/10/24
HLS Therapeutics (HLS:CN) (HLTRF) PT Lowered to Cdn$4 at Canaccord GenuityCanaccord Genuity analyst Tania Armstrong-Whitworth lowered the price target on HLS Therapeutics (HLS:CN) (OTC: HLTRF) to Cdn$4.00 (from Cdn$4.75) while maintaining a Hold rating.
Raymond James
C$5C$4
Hold
-3.61%
Downside
Reiterated
05/10/24
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HLS Therapeutics Inc

Which Analyst Should I Follow If I Want to Buy TSE:HLS and Sell After:
1 Month
xxx
Success Rate
13/32 ratings generated profit
41%
Average Return
+10.75%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 40.63% of your transactions generating a profit, with an average return of +10.75% per trade.
3 Months
xxx
Success Rate
15/32 ratings generated profit
47%
Average Return
+9.25%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.88% of your transactions generating a profit, with an average return of +9.25% per trade.
1 Year
David Martin PhDBloom Burton
Success Rate
14/32 ratings generated profit
44%
Average Return
+8.79%
reiterated a buy rating 4 months ago
Copying David Martin PhD's trades and holding each position for 1 Year would result in 43.75% of your transactions generating a profit, with an average return of +8.79% per trade.
2 Years
xxx
Success Rate
11/32 ratings generated profit
34%
Average Return
+0.07%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 34.38% of your transactions generating a profit, with an average return of +0.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HLS Analyst Recommendation Trends

Rating
Mar 24
May 24
Jul 24
Aug 24
Nov 24
Strong Buy
1
3
4
4
3
Buy
0
0
0
0
0
Hold
4
6
7
6
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
9
11
10
6
In the current month, HLS has received 3 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. HLS average Analyst price target in the past 3 months is C$9.50.
Each month's total comprises the sum of three months' worth of ratings.

HLS Stock Forecast FAQ

What is TSE:HLS’s average 12-month price target, according to analysts?
Based on analyst ratings, HLS Therapeutics Inc’s 12-month average price target is C$9.50.
    What is TSE:HLS’s upside potential, based on the analysts’ average price target?
    HLS Therapeutics Inc has 128.92% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TSE:HLS a Buy, Sell or Hold?
          HLS Therapeutics Inc has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is HLS Therapeutics Inc’s price target?
            The average price target for HLS Therapeutics Inc is C$9.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is C$9.50 ,the lowest forecast is C$9.50. The average price target represents 128.92% Increase from the current price of C$4.15.
              What do analysts say about HLS Therapeutics Inc?
              HLS Therapeutics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of TSE:HLS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis